Topical Use of Corticosteroid to Prevent Epiretinal Membrane Following Retinal Tear

NCT02412059 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Unity Health Toronto

Collaborators